Anixa Historical Income Statement
| ANIX Stock | USD 2.60 0.13 4.76% |
Historical analysis of Anixa Biosciences income statement accounts such as Selling General Administrative of 4.2 M, Total Revenue of 229.4 K or Gross Profit of 53.5 K can show how well Anixa Biosciences performed in making a profits. Evaluating Anixa Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Anixa Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Anixa Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anixa Biosciences is a good buy for the upcoming year.
Anixa |
About Anixa Income Statement Analysis
Anixa Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Anixa Biosciences shareholders. The income statement also shows Anixa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Anixa Biosciences Income Statement Chart
Anixa Biosciences Income Statement is one of the three primary financial statements used for reporting Anixa's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Anixa Biosciences revenue and expense. Anixa Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Anixa Biosciences' Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anixa Biosciences. It is also known as Anixa Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Anixa Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.
Anixa Biosciences income statement Correlations
Click cells to compare fundamentals
Anixa Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anixa Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Selling General Administrative | 5.6M | 7.1M | 7.2M | 6.3M | 7.2M | 4.2M | |
| Total Revenue | 0.0 | 512.5K | 2.5B | 210K | 241.5K | 229.4K | |
| Gross Profit | (90.2K) | 127.5K | 2.5B | 49K | 56.4K | 53.5K | |
| Other Operating Expenses | 10.0M | 13.6M | 13.9M | 11.2M | 12.9M | 6.9M | |
| Operating Income | (10.0M) | (13.1M) | (13.9M) | (11.0M) | (9.9M) | (9.4M) | |
| Ebit | (10.0M) | (13.1M) | (13.9M) | (11.0M) | (9.9M) | (9.4M) | |
| Ebitda | (9.7M) | (13.1M) | (13.8M) | (11.0M) | (9.9M) | (9.4M) | |
| Total Operating Expenses | 10.0M | 13.3M | 13.9M | 11.1M | 12.7M | 6.6M | |
| Net Income | (10.1M) | (12.9M) | (13.5M) | (9.8M) | (8.8M) | (9.3M) | |
| Income Tax Expense | 40.2K | (181.3K) | (280K) | (119K) | (136.9K) | (130.0K) | |
| Depreciation And Amortization | 238.2K | 54.4K | 42K | 46K | 52.9K | 50.3K | |
| Income Before Tax | (10.1M) | (13.1M) | (13.8M) | (9.9M) | (8.9M) | (9.4M) | |
| Total Other Income Expense Net | (114.2K) | 7.8K | 104K | 1.1M | 972.9K | 1.0M | |
| Research Development | 4.4M | 6.2M | 6.7M | 4.8M | 5.5M | 3.6M | |
| Cost Of Revenue | 90.2K | 385.0K | 42K | 161K | 185.2K | 175.9K | |
| Net Income From Continuing Ops | (9.9M) | (13.1M) | (13.8M) | (9.9M) | (8.9M) | (9.4M) | |
| Non Operating Income Net Other | 46.0K | 71.4K | 33.9K | 104K | 119.6K | 125.6K | |
| Net Income Applicable To Common Shares | (11.6M) | (10.0M) | (13.0M) | (13.6M) | (12.2M) | (12.8M) | |
| Interest Income | 33.9K | 2.3K | 104K | 1.1M | 1.2M | 1.3M | |
| Minority Interest | (74.0K) | 173.5K | (176K) | 119K | 136.9K | 143.7K | |
| Net Interest Income | 33.9K | 2.3K | 104K | 1.1M | 1.2M | 1.3M | |
| Reconciled Depreciation | 90.2K | 59.9K | 42K | 46K | 41.4K | 39.3K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Anixa Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anixa Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anixa Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anixa Biosciences Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Anixa Stock analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share 0.007 | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.